1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
These authors contributed equally to this study.
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Hepatobiliary Malignancies
You have full text access to this OnlineOpen article
Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma†
Article first published online: 19 SEP 2008
DOI: 10.1002/hep.22638
Copyright © 2008 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Bai, D.-S., Dai, Z., Zhou, J., Liu, Y.-K., Qiu, S.-J., Tan, C.-J., Shi, Y.-H., Huang, C., Wang, Z., He, Y.-F. and Fan, J. (2009), Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma. Hepatology, 49: 460–470. doi: 10.1002/hep.22638
- †
Potential conflict of interest: Nothing to report.
- ‡
These authors contributed equally to this study.
- §
fax: (86)-21-64037181
Publication History
- Issue published online: 28 JAN 2009
- Article first published online: 19 SEP 2008
- Accepted manuscript online: 19 SEP 2008 12:00AM EST
- Manuscript Accepted: 11 SEP 2008
- Manuscript Received: 19 FEB 2008
Funded by
- State 863 High Technology R&D Project of China. Grant Number: 2007AA02Z479
- Program for Outstanding Medical Academic Leader. Grant Number: LJ06004
- Specialized Research Fund for the Doctoral Program of Higher Education. Grant Number: 20070246112
Reference
- 1, , , . Global cancer statistics, 2002. CA. Cancer J Clin 2005; 55: 74–108.
- 2. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 1942–1956.
- 3, , , , , , et al. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1991; 12: 367–371.
- 4, , , , , , et al. HCV-associated hepatocellular carcinoma without cirrhosis. J Hepatol 1996; 24: 277–285.
- 5. Hepatitis C virus and hepatocellular carcinoma. Sem Liver Dis 1999; 19: 263–269.
- 6, , , , , . Liver transplantation for hepatocellular carcinoma. Ann Surg 2001; 233: 652–659.
- 7, , , . The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significant with time. J Clin Oncol 2003; 21: 4329.
- 8, , , , , , et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005; 100: 2708–2716.Direct Link:
- 9, , , , , , et al. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl 2007; 13: 543–551.
- 10, , , , , , et al. Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry. Mol Cell Proteomics 2004; 3: 399–409.
- 11, , , , , . Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS. FASEB J 2005; 19: 1809–1821.
- 12, , , , , , et al. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis. Proteomics 2006; 6: 5857–5867.
- 13, , , , , , et al. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics 2004; 3: 73–81.
- 14, , , , , , et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. HEPATOLOGY 2001; 33: 1394–1403.
- 15, , , , , , et al. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J Cancer Res Clin Oncol 2004; 130: 460–468.
- 16, , , , , , et al. Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterol 2005; 129: 1187–1197.
- 17, , . An approach to correlate tandem mass-spectral data of peptides with amino-acid-sequences in a protein database. J Am Soc Mass Spectr 1994; 5: 976–989.
- 18, , , . Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002; 74: 5383–5392.
- 19, , , . A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003; 75: 4646–4658.
- 20, , , . Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry. Anal Chem 2003; 75: 6648–6657.
- 21, , , , , , et al. Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence. HEPATOLOGY 2008; 48: 497–507.
- 22, , , , , , et al. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation 2006; 81: 1532–1541.
- 23, , , , , , et al. Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol 2005; 132: 92–98.
- 24, , , , , , et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003; 9: 416–423.
- 25, , , , , . Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999; 17: 994–999.
- 26, , , , , , et al. Expression and growth-promoting effect of adult T-cell leukemia-derived factor: a human thioredoxin homologue in hepatocellular carcinoma. Cancer 1992; 69: 2091–2097.
- 27, , . High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res 1995; 55: 675–680.
- 28, , , , , . Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res 1996; 16: 3459–3466.
- 29, , , . Thioredoxin, a gene found overexpressed in human cancer, inhibitis apoptosis in vitro and in vivo. Cancer Res 1997; 57: 5162–5167.
- 30, . Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14:18). Nature 1991; 349: 254–256.
- 31, . Nuclear shift of hnRNP K protein in neoplasms and other states of enhanced cell proliferation. Br J Cancer 2003; 89: 1493–1501.
- 32, , , , . The calpain system. Physiol Rev 2003; 83: 731–801.
- 33, , . Structure of the mouse calpain small subunit gene. Biochim Biophys Acta 1998; 1388: 247–252.
- 34, , , , , . Conditional disruption of ubiquitous calpains in the mouse. Genesis 2006; 44: 297–303.
- 35, , , . Beta1-integrin-mediated T-cell adhesion and cell spreading are regulated by calpain. Exp Cell Res 2000; 261: 260–270.
- 36, , , , , , et al. Calpain regulates actin remodeling during cell spreading. J Cell Biol 1998; 141: 647–662.
- 37, , , , , , et al. Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nat Cell Biol 2004; 6: 977–983.
- 38, . Role of calpain in skeletal-muscle protein degradation. Proc Natl Acad Sci U S A 1998; 95: 12100–12105.